Cargando…

Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis

In order to systematically evaluate the clinical efficacy and safety of misoprostol versus oxytocin in the prevention of postpartum hemorrhage, this paper provides evidence-based reference for clinical medication, computerized retrieval of Chinese biomedical literature database (CBM), PubMed, Embase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Renmei, Guo, Yongjie, Zhang, Qinggui, Zeng, Xiaokang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017444/ https://www.ncbi.nlm.nih.gov/pubmed/35449871 http://dx.doi.org/10.1155/2022/3254586

Ejemplares similares

Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage
por: Rajaei, Minoo, et al.
Publicado: (2014)

Retracted: Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage
por: Mirteimouri, Masoumeh, et al.
Publicado: (2013)

Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: A randomised controlled trial
por: Sringamwong, Wirawan, et al.
Publicado: (2022)

Oxytocin Versus Misoprostol Plus Oxytocin in the Prevention of Postpartum Hemorrhage at a Semi-Urban Hospital in sub-Saharan Africa: A Retrospective Cohort Study
por: Numfor, Emmanuel, et al.
Publicado: (2020)

Sublingual Misoprostol versus Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage in Uganda: A Double-Blind Randomized Non-Inferiority Trial
por: Atukunda, Esther C., et al.
Publicado: (2014)

Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention
por: Prata, Ndola, et al.
Publicado: (2014)

Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India
por: Cook, John R., et al.
Publicado: (2023)

Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2015)

Misoprostol for Prevention of Postpartum Hemorrhage at Home Birth in Afghanistan: Program Expansion Experience
por: Haver, Jaime, et al.
Publicado: (2016)

Correction: Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2016)

Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning
por: Prata, Ndola, et al.
Publicado: (2016)

Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach
por: Koch, Daeska Marcella, et al.
Publicado: (2019)

Outcome of misoprostol and oxytocin in induction of labour
por: Acharya, Trishna, et al.
Publicado: (2017)

Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date
por: Smith, Jeffrey Michael, et al.
Publicado: (2013)

Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia
por: Smith, Jeffrey Michael, et al.
Publicado: (2014)

Quality of oxytocin and misoprostol in health facilities of Rwanda
por: Bizimana, Thomas, et al.
Publicado: (2021)

Carbetocin vs oxytocin for prevention of postpartum hemorrhage after vaginal delivery: A meta-analysis
por: Jin, Xin-Hang, et al.
Publicado: (2019)

Quality, availability and storage conditions of oxytocin and misoprostol in Malawi
por: Hagen, Nhomsai, et al.
Publicado: (2020)

Comparison effect of intravenous tranexamic acid and misoprostol for postpartum haemorrhage
por: Sahhaf, Farnaz, et al.
Publicado: (2014)

Oxytocin quality: evidence to support updated global recommendations on oxytocin for postpartum hemorrhage
por: Lambert, Peter, et al.
Publicado: (2020)

The effect of carbetocin compared to misoprostol in management of the third stage of labor and prevention of postpartum hemorrhage: a systematic review
por: Abd El Aziz, Mohamed A., et al.
Publicado: (2018)

A Comparative Study of the Efficacy and Safety of Oral Misoprostol, Intravenous Oxytocin, and Intravaginal Dinoprostone for Labor Induction in Pakistani Women
por: Wasim, Asad Ullah, et al.
Publicado: (2023)

Effects of a New Patient Safety-Driven Oxytocin Dosing Protocol on Postpartum Hemorrhage
por: McKenna, David S., et al.
Publicado: (2014)

A comparison of oxytocin and carboprost tromethamine in the prevention of postpartum hemorrhage in high-risk patients undergoing cesarean delivery
por: BAI, JING, et al.
Publicado: (2014)

Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage
por: Zgaya, Rym, et al.
Publicado: (2020)

Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
por: Kibira, Denis, et al.
Publicado: (2021)

A comparative study on infusion of usual dose of oxytocin and 80 units dose of oxytocin in the prevention of postpartum hemorrhage in cesarean section
por: Ahmadi, Fatemeh
Publicado: (2018)

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
por: León, Wilfrido, et al.
Publicado: (2012)

Oxytocin receptor DNA methylation is associated with exogenous oxytocin needs during parturition and postpartum hemorrhage
por: Erickson, Elise N., et al.
Publicado: (2023)

Low-dose oxytocin - a safe strategy in postpartum hemorrhage
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Misoprostol for the prevention of postpartum hemorrhage during home births in rural Lao PDR: establishing a pilot program for community distribution
por: Durham, Jo, et al.
Publicado: (2018)

Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings
por: Lang, Danielle L., et al.
Publicado: (2015)

Clinical guidelines—the challenges and opportunities: What we have learned from the case of misoprostol for postpartum hemorrhage
por: Morris, Jessica L., et al.
Publicado: (2018)

Scaling Up Misoprostol to Prevent Postpartum Hemorrhage at Home Births in Mozambique: A Case Study Applying the ExpandNet/WHO Framework
por: Hobday, Karen, et al.
Publicado: (2019)

High fever following postpartum administration of sublingual misoprostol
por: Durocher, J, et al.
Publicado: (2010)

Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
por: Nasreen, Hashima-E-, et al.
Publicado: (2011)

Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage – Do Costs Matter?
por: Chatterjee, Susmita, et al.
Publicado: (2016)

Misoprostol as an adjunct to oxytocin can reduce postpartum-haemorrhage: a propensity score–matched retrospective chart review in Bamenda-Cameroon, 2015–2016
por: Morfaw, Frederick, et al.
Publicado: (2019)

Quality of oxytocin and tranexamic acid for the prevention and treatment of postpartum hemorrhage in Kenya, Nigeria, South Africa, and Tanzania
por: Ammerdorffer, Anne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8c993ugfb269opd91nihai6n8d